Amazon puts the new obesity pill into same-day kiosks

Amazon said on April 9, 2026, that its pharmacy unit will stock Eli Lilly's new weight-loss pill Foundayo at kiosks located at some of the company's health clinics and will offer same-day delivery of the drug ^[1][2]. The company said this is the fastest consumer distribution any obesity drug has received at launch ^[1].

Unlike injectable GLP-1 drugs, which need refrigeration and cannot be stocked in kiosks, Foundayo is a pill that does not require cold storage, which Amazon Pharmacy vice president Tanvi Patel said "allows for broader access and for them to be stored safely in a kiosk for dispensing" ^[1]. About half of U.S. customers currently have access to same-day delivery, and Amazon said it aims to expand that reach, with all customers guaranteed to receive their medications within four days ^[1][2].

Customers need a prescription to order Foundayo through Amazon Pharmacy ^[2]. Lilly said it would sell Foundayo directly to cash-pay customers through its LillyDirect platform at $149 per month for the lowest dose, with additional monthly doses costing up to $349, and higher doses starting between $299 and $349 for a one-month prescription ^[1][2]. Lilly and Amazon said people with insurance that covers GLP-1 weight-loss drugs might pay as little as $25 per month ^[2]. Consumers can also access Amazon's same-day delivery through Lilly prescribing partners such as WeightWatchers, and other options include the telehealth provider Ro and LifeMD ^[1][2].

Amazon Pharmacy began delivering GLP-1 medications in 2021 and has stocked Novo Nordisk's Wegovy pill in kiosks since January ^[1]. That pill is currently available in five kiosks in California, at Amazon's One Medical locations, where customers can pick it up after a medical appointment ^[1][2]. Patel said Amazon benefits from being Lilly's dispensing pharmacy because of the drugmaker's early focus on direct-to-consumer sales ^[1].

Why it matters for patients

For patients, the practical change is speed and convenience rather than a new medication itself. Because Foundayo does not need refrigeration, it can sit on a kiosk shelf the way antibiotics or blood pressure pills do, which Amazon says cuts shipping costs and barriers to access ^[1]. That could matter for people who want to start treatment quickly or who have struggled with the logistics of receiving injectable drugs that require cold-chain shipping.

Cost still varies widely depending on insurance. The $149 starting price applies only to cash-pay customers on the lowest dose, while other doses run as high as $349 per month without insurance, and insured patients could pay closer to $25 a month ^[1][2]. Patients without a One Medical membership can still book an appointment and use a kiosk, though a one-year membership costs $199 ^[1][2].

What happens next

Amazon's kiosks for Wegovy have so far been limited to five One Medical locations in Los Angeles, and the company has said it plans to expand nationally, though the pace depends on state regulation ^[1][2]. Patel said that as kiosks expand beyond California, they may appear at other providers or clinics if state rules allow ^[1]. Separately, Amazon said it invested more than $4 billion in 2025 to triple its company-wide delivery options this year, targeting underserved small towns and rural areas, with a goal of reaching same-day delivery in 4,500 locales by the end of 2026 ^[1]. It is not yet known how quickly Foundayo kiosks specifically will roll out beyond the initial markets, or how insurance coverage decisions by individual health plans will affect the $25 figure cited by Lilly and Amazon ^[1][2].